PRESS RELEASE published on 06/27/2023 at 13:16, 1 year 4 months ago First physical Annual General Meeting of Bike24 Holding AG: focus on further international expansion
PRESS RELEASE published on 05/03/2023 at 07:30, 1 year 6 months ago BIKE24 doubles sales in localized markets during Q1 2023 – ongoing subdued consumer sentiment in the DACH region
PRESS RELEASE published on 03/30/2023 at 07:30, 1 year 7 months ago BIKE24 continues growth path in fiscal year 2022 – international markets and full-bike sales are pillars of success
PRESS RELEASE published on 03/14/2023 at 09:00, 1 year 8 months ago BIKE24: Localized online stores for Benelux launched
PRESS RELEASE published on 02/17/2023 at 11:15, 1 year 9 months ago BIKE24 with solid final quarter: FY 2022 sales growth with 4.5 percent at upper end of guidance range
PRESS RELEASE published on 02/17/2023 at 11:11, 1 year 9 months ago EQS-Adhoc: Bike24 Holding AG: Upcoming extension of syndicated loan agreement at adjusted terms and conditions
Published on 11/21/2024 at 12:00, 37 minutes ago Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 37 minutes ago Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 7 minutes ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 34 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 37 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 12:15, 22 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 7 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:00, 1 hour 37 minutes ago First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 06:58, 5 hours 39 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 17 hours 17 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 18 hours 52 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 18 hours 52 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 4 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
